FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2206774046> ?p ?o ?g. }

• W2206774046 endingPage "103" @default.
• W2206774046 startingPage "1097" @default.
• W2206774046 abstract "Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to declines of about 30% in the global annual number of human immunodeficiency (HIV)-related deaths and declines in global HIV incidence, estimated annual HIV-related deaths among adolescents have increased by about 50% and estimated adolescent HIV incidence has been relatively stable. In 2012, an estimated 2,500 (40%) of all 6,300 daily new HIV infections occurred among persons aged 15-24 years. Difficulty enrolling adolescents and young adults in ART and high rates of loss to follow-up (LTFU) after ART initiation might be contributing to mortality and HIV incidence in this age group, but data are limited. To evaluate age-related ART retention challenges, data from retrospective cohort studies conducted in seven African countries among 16,421 patients, aged ≥15 years at enrollment, who initiated ART during 2004-2012 were analyzed. ART enrollment and outcome data were compared among three groups defined by age at enrollment: adolescents and young adults (aged 15-24 years), middle-aged adults (aged 25-49 years), and older adults (aged ≥50 years). Enrollees aged 15-24 years were predominantly female (81%-92%), commonly pregnant (3%-32% of females), unmarried (54%-73%), and, in four countries with employment data, unemployed (53%-86%). In comparison, older adults were more likely to be male (p<0.001), employed (p<0.001), and married, (p<0.05 in five countries). Compared with older adults, adolescents and young adults had higher LTFU rates in all seven countries, reaching statistical significance in three countries in crude and multivariable analyses. Evidence-based interventions to reduce LTFU for adolescent and young adult ART enrollees could help reduce mortality and HIV incidence in this age group." @default.
• W2206774046 created "2016-06-24" @default.
• W2206774046 creator A5004544934 @default.
• W2206774046 creator A5006087600 @default.
• W2206774046 creator A5006842660 @default.
• W2206774046 creator A5008037847 @default.
• W2206774046 creator A5008235594 @default.
• W2206774046 creator A5015825067 @default.
• W2206774046 creator A5016429571 @default.
• W2206774046 creator A5023476225 @default.
• W2206774046 creator A5026076483 @default.
• W2206774046 creator A5026091946 @default.
• W2206774046 creator A5026331491 @default.
• W2206774046 creator A5026710199 @default.
• W2206774046 creator A5029484343 @default.
• W2206774046 creator A5030685765 @default.
• W2206774046 creator A5034123739 @default.
• W2206774046 creator A5037235757 @default.
• W2206774046 creator A5037878640 @default.
• W2206774046 creator A5041993567 @default.
• W2206774046 creator A5044645935 @default.
• W2206774046 creator A5045479933 @default.
• W2206774046 creator A5048276116 @default.
• W2206774046 creator A5048294184 @default.
• W2206774046 creator A5049031267 @default.
• W2206774046 creator A5057941585 @default.
• W2206774046 creator A5059697107 @default.
• W2206774046 creator A5060621329 @default.
• W2206774046 creator A5063800315 @default.
• W2206774046 creator A5065318803 @default.
• W2206774046 creator A5068576041 @default.
• W2206774046 creator A5070223819 @default.
• W2206774046 creator A5071746762 @default.
• W2206774046 creator A5072682299 @default.
• W2206774046 creator A5073389592 @default.
• W2206774046 creator A5074151617 @default.
• W2206774046 creator A5074328800 @default.
• W2206774046 creator A5079005738 @default.
• W2206774046 creator A5084302241 @default.
• W2206774046 creator A5084961491 @default.
• W2206774046 creator A5086134502 @default.
• W2206774046 creator A5086471106 @default.
• W2206774046 creator A5088258773 @default.
• W2206774046 creator A5089906317 @default.
• W2206774046 date "2014-11-28" @default.
• W2206774046 modified "2023-10-17" @default.
• W2206774046 title "Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013." @default.
• W2206774046 cites W1889532030 @default.
• W2206774046 cites W1964875148 @default.
• W2206774046 cites W1980032585 @default.
• W2206774046 cites W2022456886 @default.
• W2206774046 cites W2031368727 @default.
• W2206774046 cites W2086606929 @default.
• W2206774046 cites W2089423345 @default.
• W2206774046 cites W2113676816 @default.
• W2206774046 cites W2152505869 @default.
• W2206774046 cites W2163546699 @default.
• W2206774046 cites W2587668524 @default.
• W2206774046 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5779521" @default.
• W2206774046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25426651" @default.
• W2206774046 hasPublicationYear "2014" @default.
• W2206774046 type Work @default.
• W2206774046 sameAs 2206774046 @default.
• W2206774046 citedByCount "61" @default.
• W2206774046 countsByYear W22067740462015 @default.
• W2206774046 countsByYear W22067740462016 @default.
• W2206774046 countsByYear W22067740462017 @default.
• W2206774046 countsByYear W22067740462018 @default.
• W2206774046 countsByYear W22067740462019 @default.
• W2206774046 countsByYear W22067740462020 @default.
• W2206774046 countsByYear W22067740462021 @default.
• W2206774046 countsByYear W22067740462022 @default.
• W2206774046 countsByYear W22067740462023 @default.
• W2206774046 crossrefType "journal-article" @default.
• W2206774046 hasAuthorship W2206774046A5004544934 @default.
• W2206774046 hasAuthorship W2206774046A5006087600 @default.
• W2206774046 hasAuthorship W2206774046A5006842660 @default.
• W2206774046 hasAuthorship W2206774046A5008037847 @default.
• W2206774046 hasAuthorship W2206774046A5008235594 @default.
• W2206774046 hasAuthorship W2206774046A5015825067 @default.
• W2206774046 hasAuthorship W2206774046A5016429571 @default.
• W2206774046 hasAuthorship W2206774046A5023476225 @default.
• W2206774046 hasAuthorship W2206774046A5026076483 @default.
• W2206774046 hasAuthorship W2206774046A5026091946 @default.
• W2206774046 hasAuthorship W2206774046A5026331491 @default.
• W2206774046 hasAuthorship W2206774046A5026710199 @default.
• W2206774046 hasAuthorship W2206774046A5029484343 @default.
• W2206774046 hasAuthorship W2206774046A5030685765 @default.
• W2206774046 hasAuthorship W2206774046A5034123739 @default.
• W2206774046 hasAuthorship W2206774046A5037235757 @default.
• W2206774046 hasAuthorship W2206774046A5037878640 @default.
• W2206774046 hasAuthorship W2206774046A5041993567 @default.
• W2206774046 hasAuthorship W2206774046A5044645935 @default.
• W2206774046 hasAuthorship W2206774046A5045479933 @default.
• W2206774046 hasAuthorship W2206774046A5048276116 @default.
• W2206774046 hasAuthorship W2206774046A5048294184 @default.
• W2206774046 hasAuthorship W2206774046A5049031267 @default.
• W2206774046 hasAuthorship W2206774046A5057941585 @default.

• next